Search

Search Constraints

You searched for: Author/Creator van Steenoven, Inger

Search Results

1. [P1–243]: ALPHA‐SYNUCLEIN SPECIES AS POTENTIAL CSF BIOMARKERS FOR DEMENTIA WITH LEWY BODIES. (1st July 2017)

2. [P2–242]: PROTEOMICS IDENTIFICATION OF NOVEL CEREBROSPINAL FLUID BIOMARKER CANDIDATES OF DEMENTIA WITH LEWY BODIES. (1st July 2017)

4. Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia. Issue 8 (14th June 2016)

6. Conversion between Mini‐Mental State Examination, Montreal Cognitive Assessment, and Dementia Rating Scale‐2 scores in Parkinson's disease. Issue 14 (7th November 2014)

7. CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies. Issue 1 (31st July 2019)

9. Disease progression in dementia with Lewy bodies: A longitudinal study on clinical symptoms, quality of life and functional impairment. (20th November 2022)

10. Mild cognitive impairment with Lewy bodies: Clinical characteristics and risk factors for progression: Neuropsychiatry and behavioral neurology: DLB and FTD — clinical manifestations. (7th December 2020)